Tearsheet

Accelerant (ARX)

Market Price (10/31/2025): $11.33 | Market Cap: $2.5 Bil
Sector: Financials | Industry: Insurance Brokers

Accelerant (ARX)

Market Price (10/31/2025): $11.33
Market Cap: $2.5 Bil
Sector: Financials
Industry: Insurance Brokers

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -83%	Weak multi-year price returns 2Y Excs Rtn is -57%, 3Y Excs Rtn is -69%	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 40x, P/EPrice/Earnings or Price/(Net Income) is 186x
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 91%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 86%		Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.9%
2	Attractive yield FCF Yield is 22%		High stock price volatility Vol 12M is 158%

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -83%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 91%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 86%
2	Attractive yield FCF Yield is 22%
3	Weak multi-year price returns 2Y Excs Rtn is -57%, 3Y Excs Rtn is -69%
4	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 40x, P/EPrice/Earnings or Price/(Net Income) is 186x
5	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.9%
6	High stock price volatility Vol 12M is 158%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/31/25	2024	2023	2022	2021
Share Price CYE	$11.33	$10.50	$10.50	$10.50	$10.50
Market Cap CYE ($ Bil)	2.5	1.7	1.7	1.7	2.3
Total Debt ($ Bil)	0.1	0.1	0.1	0.1	0.0
Total Cash ($ Bil)	1.5	1.3	0.8	0.4	0.3
Enterprise Value ($ Bil)	1.2	1.8	1.8	1.8	2.3
Valuation Ratios
P/S TTM	3.9	3.0	5.3	8.2	16.5
P/EBIT TTM	39.8	34.0	-52.7	-21.7	-99.8
P/E TTM	186.0	64.1	-35.6	-19.0	-79.4
Sector Ratios
P/S TTM (Sector)	3.0	3.0	2.8	2.7	3.3
P/EBIT TTM (Sector)	6.8	6.8	7.0	6.2	6.8
P/E TTM (Sector)	11.8	11.5	10.1	9.3	9.9

	10/31/25	2024	2023
Share Price CYE	$11.33	$10.50	$10.50
Market Cap CYE ($ Bil)	2.5	1.7	1.7
Total Debt ($ Bil)	0.1	0.1	0.1
Total Cash ($ Bil)	1.5	1.3	0.8
Enterprise Value ($ Bil)	1.2	1.8	1.8
Valuation Ratios
P/S TTM	3.9	3.0	5.3
P/EBIT TTM	39.8	34.0	-52.7
P/E TTM	186.0	64.1	-35.6
Sector Ratios
P/S TTM (Sector)	3.0	3.0	2.8
P/EBIT TTM (Sector)	6.8	6.8	7.0
P/E TTM (Sector)	11.8	11.5	10.1

	ARX	S&P 500
REVENUE GROWTH	GOOD
Rev LTM ($ Bil)	0.6
Rev Chg Q	101.2%	6.4%
Rev Chg LTM	�	5.4%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	�
CFO LTM ($ Bil)	0.6
Net Inc LTM ($ Bil)	0.0
CFO/Rev LTM	91.0%	20.4%
Net Inc Mgn	2.1%	12.8%
VALUATION	MODERATE
P/S	3.9	3.2
P/CFO	4.3	15.5
P/FCF	4.6	20.6
P/E	186.0	23.6

ARX Stock

Return (1M):

Factor Drivers of Stock Movement

The -58.8% change in ARX stock from 7/31/2025 to 10/30/2025 was primarily driven by a 0.0% change in the company's Shares Outstanding (Mil).

	7312025	10302025	Change
Stock Price ($)	27.54	11.35	-58.79%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	�	425.30	�
P/S Multiple	�	4.34	�
Shares Outstanding (Mil)	162.50	162.50	0.00%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

The 8.1% change in ARX stock from 5/1/2025 to 10/30/2025 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).

	5012025	10302025	Change
Stock Price ($)	10.50	11.35	8.10%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	�	425.30	�
P/S Multiple	�	4.34	�
Shares Outstanding (Mil)	162.50	162.50	0.00%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

The 8.1% change in ARX stock from 10/30/2024 to 10/30/2025 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).

	10302024	10302025	Change
Stock Price ($)	10.50	11.35	8.10%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	�	425.30	�
P/S Multiple	�	4.34	�
Shares Outstanding (Mil)	162.50	162.50	0.00%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

null

null

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
ARX Return	0%	0%	0%	0%	0%	8%	19%
Peers Return	3%	22%	-15%	-10%	4%	-29%	-30%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	110%
Monthly Win Rates [3]
ARX Win Rate	0%	0%	0%	0%	0%	11%
Peers Win Rate	36%	47%	28%	37%	57%	42%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
ARX Max Drawdown	0%	0%	0%	0%	0%	0%
Peers Max Drawdown	-12%	-4%	-26%	-19%	-13%	-31%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: WTW, TIRX, ZBAO, MMC, AON.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

null

In The Past

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Accelerant (ARX)

Business Description

N/A

Better Bets than Accelerant (ARX)

	ARX	Better Performance than ARX
Metric	Value	Industry (Insurance Brokers)
CFO/Rev LTM	91.0%
FCF/Rev LTM	86.0%
Total Yield	0.5%	MMC (6.6%), AON (4.5%), AJG (2.9%), WTW (1.3%), BRO (4.4%)

	ARX	Better Performance than ARX
Metric	Value	Sector (Financials)
CFO/Rev LTM	91.0%	RY (135.4%), IBKR (157.8%), NLY (123.7%), AGNC (92.3%), XP (145.7%)
FCF/Rev LTM	86.0%	RY (131.7%), IBKR (157.2%), AGNC (92.3%), XP (140.4%), JXN (103.0%)
Total Yield	0.5%	JPM (6.6%), V (3.7%), MA (2.6%), BAC (6.8%), WFC (9.3%)

	ARX	Better Performance than ARX
Metric	Value	All Other Sectors
CFO/Rev LTM	91.0%	RPRX (104.4%), CTRE (113.6%), GSAT (223.4%), MDU (102.5%), ORLA (101.2%)
FCF/Rev LTM	86.0%	RPRX (104.4%), CTRE (108.7%), GSAT (100.6%), KURA (147.5%), TBPH (317.1%)
Total Yield	0.5%	NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)

		Best Bets In Financials Sector
	ARX	DBRG	OTF	MTG	NMIH	CACC	ENVA	FNF	ACGL	APAM	FI
What You Pay
P/E	186.3	39.7	13.2	8.4	7.5	12.3	10.2	13.9	8.6	10.5	10.6
P/EBIT	39.9	64.7	9.0	6.4	5.5	9.9	7.8	8.9	7.6	6.1	5.8
What You Get
Rev Chg Q	101.2%	-102.4%	1,228.5%	-0.7%	7.2%	8.3%	16.3%	16.8%	22.4%	4.4%	8.0%
Rev Chg LTM	�	-84.8%	89.0%	2.2%	10.0%	12.5%	21.1%	7.4%	23.5%	10.0%	6.7%
Rev Chg 3Y Avg	�	125.8%	221.9%	1.2%	10.1%	6.9%	23.5%	-0.7%	29.8%	0.2%	7.5%
FCF/Rev 3Y Avg	�	101.2%	76.2%	62.2%	58.8%	57.1%	54.7%	50.8%	38.4%	29.0%	20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	With Accelerant Stock Down 21% In A Month, How Confident Are You?	Return

	Title
0	ARTICLES
1	With Accelerant Stock Down 21% In A Month, How Confident Are You?

Trade Ideas

Select past ideas related to ARX. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	279.1%	161.2%
2	INBX	Inhibrx Biosciences	131.0%	409.8%
3	PUMP	ProPetro	99.6%	16.2%
4	DYN	Dyne Therapeutics	88.4%	-0.0%
5	VICR	Vicor	85.4%	89.2%
6	CELC	Celcuity	74.6%	503.2%
7	GLUE	Monte Rosa Therapeutics	73.5%	87.5%
8	NVTS	Navitas Semiconductor	72.1%	251.8%
9	LUMN	Lumen Technologies	70.3%	94.7%
10	BALY	Ballys	63.4%	4.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-62.9%	5106.3%
2	LRN	Stride	-53.8%	-35.8%
3	FMC	FMC	-51.0%	-66.6%
4	FI	Fiserv	-48.3%	-68.3%
5	NFE	New Fortress Energy	-43.6%	-91.9%
6	VG	Venture Global	-41.7%
7	OGN	Organon	-40.2%	-55.0%
8	VRNS	Varonis Systems	-39.5%	-21.2%
9	ITGR	Integer	-38.5%	-52.2%
10	LENZ	LENZ Therapeutics	-37.9%	5.5%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

Peer Comparisons for Accelerant

Financials

	ARX	WTW	TIRX	ZBAO	MMC	AON	Median
Name	Accelera.	Willis T.	Tian Rui.	Zhibao T.	Marsh & .	Aon
Mkt Price	11.35	317.00	0.98	1.00	178.67	328.19	95.01
Mkt Cap	2.5	31.4	-	-	87.7	71.0	51.2
Rev LTM	634	9,808	-	-	26,453	16,752	13,280
Op Inc LTM	-	2,206	-	-	6,146	4,305	4,305
FCF LTM	545	1,179	-	-	4,825	2,912	2,046
FCF 3Y Avg	-	1,010	-	-	4,057	2,925	2,925
CFO LTM	577	1,407	-	-	5,087	3,149	2,278
CFO 3Y Avg	-	1,246	-	-	4,398	3,165	3,165

Growth & Margins

	ARX	WTW	TIRX	ZBAO	MMC	AON	Median
Name	Accelera.	Willis T.	Tian Rui.	Zhibao T.	Marsh & .	Aon
Rev Chg LTM	-	1.3%	-	-	10.5%	18.3%	10.5%
Rev Chg 3Y Avg	-	3.4%	-	-	8.3%	10.6%	8.3%
Rev Chg Q	101.2%	-0.2%	-	-	11.5%	10.5%	11.0%
QoQ Delta Rev Chg LTM	19.3%	-0.0%	-	-	2.5%	2.4%	2.5%
Op Mgn LTM	-	22.5%	-	-	23.2%	25.7%	23.2%
Op Mgn 3Y Avg	-	20.5%	-	-	23.1%	27.3%	23.1%
QoQ Delta Op Mgn LTM	-	0.6%	-	-	-0.3%	0.3%	0.3%
CFO/Rev LTM	91.0%	14.3%	-	-	19.2%	18.8%	19.0%
CFO/Rev 3Y Avg	-	13.0%	-	-	18.1%	22.0%	18.1%
FCF/Rev LTM	86.0%	12.0%	-	-	18.2%	17.4%	17.8%
FCF/Rev 3Y Avg	-	10.6%	-	-	16.7%	20.3%	16.7%

Valuation

	ARX	WTW	TIRX	ZBAO	MMC	AON	Median
Name	Accelera.	Willis T.	Tian Rui.	Zhibao T.	Marsh & .	Aon
Mkt Cap	2.5	31.4	-	-	87.7	71.0	51.2
P/S	3.9	3.2	-	-	3.3	4.2	3.6
P/EBIT	39.9	55.1	-	-	13.6	17.2	28.5
P/E	186.3	229.1	-	-	21.3	27.3	106.8
P/CFO	4.3	22.3	-	-	17.2	22.5	19.8
Total Yield	0.5%	1.3%	-	-	6.6%	4.5%	2.9%
Dividend Yield	0.0%	0.9%	-	-	1.9%	0.8%	0.9%
FCF Yield 3Y Avg	-	3.6%	-	-	4.0%	4.2%	4.0%
D/E	0.1	0.2	-	-	0.2	0.3	0.2
Net D/E	-0.8	0.1	-	-	0.2	0.1	0.1

Returns

	ARX	WTW	TIRX	ZBAO	MMC	AON	Median
Name	Accelera.	Willis T.	Tian Rui.	Zhibao T.	Marsh & .	Aon
1M Rtn	-23.8%	-8.2%	-52.4%	0.0%	-11.3%	-8.0%	-9.8%
3M Rtn	-58.8%	0.6%	-80.8%	14.9%	-9.9%	-7.7%	-8.8%
6M Rtn	8.1%	4.1%	-85.9%	-10.3%	-19.5%	-6.4%	-8.4%
12M Rtn	8.1%	9.2%	-89.9%	-68.3%	-17.9%	-10.5%	-14.2%
3Y Rtn	8.1%	51.0%	-98.6%	-	15.7%	19.2%	15.7%
1M Excs Rtn	-21.6%	-9.5%	-54.5%	-7.3%	-12.9%	-10.5%	-11.7%
3M Excs Rtn	-67.1%	-8.4%	-89.2%	-7.3%	-18.6%	-16.5%	-17.6%
6M Excs Rtn	-13.6%	-17.7%	-107.7%	-32.1%	-41.3%	-28.2%	-30.1%
12M Excs Rtn	-9.1%	-7.4%	-107.7%	-85.2%	-35.3%	-28.2%	-31.7%
3Y Excs Rtn	-68.7%	-20.9%	-175.4%	-	-54.8%	-56.7%	-56.7%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Filing Date	8/28/2025	7/25/2025	7/25/2025	10/20/2023	10/20/2023
Key Financials
Total Revenue	634	585	326	213	103
Net Income	13	27	-49	-92	-22
EPS	0.06	0.16	-0.29	-0.55	-0.13
Growth Rates
Total Revenue Growth	-	79.6%	52.7%	106.5%	-
Net Income Growth	-	155.7%	46.8%	-326.5%	-
Margins
Net Income Margin	2.1%	4.7%	-15.0%	-43.0%	-20.8%
Cash & Debt
Total Cash	2,210	1,817	870	509	340
Total Debt	127	121	120	100	50
Net Debt / (Cash)	-2,083	-1,696	-750	-408	-290
Cash Flows
Net Cash from Operations	577	786	290	66	113
Free Cash from Operations	545	751	257	39	98
Returns to Shareholders
Dividends	0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q2	2024Q1	2023Q4	2022Q4
Period End	6/30/2025	3/31/2025	6/30/2024	3/31/2024	12/31/2023	12/31/2022
Filing Date	8/28/2025	7/25/2025	8/28/2025	7/25/2025	7/25/2025	10/20/2023
Key Financials Quarterly
Total Revenue	204	171	130	129	102	65
Net Income	9	6	-9	7	-3	-18
EPS	0.04	0.04	-0.06	0.04	-0.02	-0.11
Key Financials TTM
Total Revenue TTM	634	531	425	-	-	-
Net Income TTM	13	2	-22	-	-	-
Growth Rates Quarterly
Total Revenue Growth	101.2%	163.8%	-	-	-	-
Net Income Growth	414.3%	136.7%	-	-	-	-
Margins Quarterly
Net Income Margin	4.3%	3.8%	-6.9%	5.5%	-2.8%	-27.4%
Cash & Debt
Total Cash	2,210	1,886	-	-	870	509
Total Debt	127	122	0	0	120	100
Net Debt / (Cash)	-2,083	-1,764	-	-	-750	-408
Cash Flows Quarterly
FCF from Operations	218	92	123	144	99	0
Cash Flows TTM
FCF from Operations TTM	577	458	367	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-	18.8%	-	-	-	-57.8%
Return on Invested Capital (ROIC) TTM
ROIC TTM	-	11.6%	-	-	-	-

	1M	2M	3M	6M	1Y	3Y
Beta	-1.30	0.10	-0.33	-0.04	-0.00	-0.00
Up Beta	-1.50	3.39	-14.21	-0.83	-0.63	-0.35
Down Beta	-15.44	-2.05	-1.81	-0.23	-0.17	-0.09
Up Capture	-243%	-243%	462%	113%	52%	5%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	7	18	21	21	21	21
Down Capture	493%	257%	260%	75%	44%	28%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	14	23	26	26	26	26

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	1,944,868
Short Interest: % Change Since 9302025	-37.6%
Average Daily Volume	1,428,745
Days-to-Cover Short Interest	1.36
Basic Shares Quantity	219,986,563
Short % of Basic Shares	0.9%

Returns Analyses

	Title
0	With Accelerant Stock Down 21% In A Month, How Confident Are You?

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/28/2025	-26.4%	-29.8%	-49.4%
SUMMARY STATS
# Positive	0	0	0
# Negative	1	1	1
Median Positive
Median Negative	-26.4%	-29.8%	-49.4%
Max Positive
Max Negative	-26.4%	-29.8%	-49.4%

	Forward Returns
8/28/2025	-26.4%	-29.8%	-49.4%
SUMMARY STATS
# Positive	0	0	0
# Negative	1	1	1
Median Positive
Median Negative	-26.4%	-29.8%	-49.4%
Max Positive
Max Negative	-26.4%	-29.8%	-49.4%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8282025	10-Q 6/30/2025
12312024	7252025	424B4 12/31/2024
9302023	11292023	DRS/A 9/30/2023
12312022	10202023	DRS 12/31/2022

Insider Activity

Expand for More

Industry Resources

Financials Resources

Federal Reserve Economic Data

Insurance Brokers Resources

Insurance Business America

A.M. Best

National Underwriter

Insurance News

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Accelerant (ARX)

Market Price (10/31/2025): $11.33 | Market Cap: $2.5 BilSector: Financials | Industry: Insurance Brokers

Accelerant (ARX)

Market Price (10/31/2025): $11.33Market Cap: $2.5 BilSector: FinancialsIndustry: Insurance Brokers

Market Valuation & Key Metrics

ARX Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Accelerant (ARX)

Interactive Breakdown

Better Bets than Accelerant (ARX)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Accelerant

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/31/2025): $11.33 | Market Cap: $2.5 Bil
Sector: Financials | Industry: Insurance Brokers

Market Price (10/31/2025): $11.33
Market Cap: $2.5 Bil
Sector: Financials
Industry: Insurance Brokers